

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | tolerance induction (GO:0002507) | 7.64068395 |
| 2 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 6.66243288 |
| 3 | response to muramyl dipeptide (GO:0032495) | 6.19461195 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.57670765 |
| 5 | interferon-gamma production (GO:0032609) | 5.48124232 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.38685350 |
| 7 | negative regulation of cell killing (GO:0031342) | 5.35309856 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.35309856 |
| 9 | response to interleukin-15 (GO:0070672) | 5.30163946 |
| 10 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 5.10328944 |
| 11 | NIK/NF-kappaB signaling (GO:0038061) | 5.00924737 |
| 12 | regulation of gamma-delta T cell activation (GO:0046643) | 4.97902948 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.97671327 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.97671327 |
| 15 | cellular response to interleukin-15 (GO:0071350) | 4.82874537 |
| 16 | negative regulation of bone resorption (GO:0045779) | 4.78821165 |
| 17 | positive thymic T cell selection (GO:0045059) | 4.74571752 |
| 18 | negative T cell selection (GO:0043383) | 4.71216919 |
| 19 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.68644172 |
| 20 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.67165409 |
| 21 | viral protein processing (GO:0019082) | 4.66124800 |
| 22 | negative thymic T cell selection (GO:0045060) | 4.46214746 |
| 23 | positive T cell selection (GO:0043368) | 4.39353384 |
| 24 | endothelial cell chemotaxis (GO:0035767) | 4.39090815 |
| 25 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.35331696 |
| 26 | thymic T cell selection (GO:0045061) | 4.19977825 |
| 27 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 4.18454696 |
| 28 | T cell selection (GO:0045058) | 4.07135584 |
| 29 | regulation of chronic inflammatory response (GO:0002676) | 4.05118899 |
| 30 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.97020391 |
| 31 | negative regulation of bone remodeling (GO:0046851) | 3.87498568 |
| 32 | response to peptidoglycan (GO:0032494) | 3.80669542 |
| 33 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.77972434 |
| 34 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.75940423 |
| 35 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.74018029 |
| 36 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.67155008 |
| 37 | detection of other organism (GO:0098543) | 3.56992325 |
| 38 | mature B cell differentiation involved in immune response (GO:0002313) | 3.55393822 |
| 39 | detection of bacterium (GO:0016045) | 3.54071085 |
| 40 | negative regulation of interleukin-12 production (GO:0032695) | 3.49194689 |
| 41 | T-helper cell differentiation (GO:0042093) | 3.48018355 |
| 42 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.48018355 |
| 43 | positive regulation by symbiont of host defense response (GO:0052509) | 3.47635512 |
| 44 | modulation by symbiont of host defense response (GO:0052031) | 3.47635512 |
| 45 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.47635512 |
| 46 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.47635512 |
| 47 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.47635512 |
| 48 | modulation by symbiont of host immune response (GO:0052553) | 3.47635512 |
| 49 | regulation of T cell tolerance induction (GO:0002664) | 3.45416454 |
| 50 | mature B cell differentiation (GO:0002335) | 3.43639004 |
| 51 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.37769611 |
| 52 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.37518081 |
| 53 | neutrophil activation involved in immune response (GO:0002283) | 3.35983291 |
| 54 | negative regulation of tissue remodeling (GO:0034104) | 3.34723386 |
| 55 | regulation of response to interferon-gamma (GO:0060330) | 3.34101965 |
| 56 | negative regulation of T cell mediated immunity (GO:0002710) | 3.31254166 |
| 57 | type I interferon signaling pathway (GO:0060337) | 3.30648152 |
| 58 | cellular response to type I interferon (GO:0071357) | 3.30648152 |
| 59 | positive regulation of interleukin-2 production (GO:0032743) | 3.29907156 |
| 60 | response to type I interferon (GO:0034340) | 3.29123726 |
| 61 | virion assembly (GO:0019068) | 3.28963916 |
| 62 | T cell migration (GO:0072678) | 3.28250723 |
| 63 | negative regulation of innate immune response (GO:0045824) | 3.27077633 |
| 64 | regulation of germinal center formation (GO:0002634) | 3.26718899 |
| 65 | T cell receptor signaling pathway (GO:0050852) | 3.26549804 |
| 66 | macrophage activation involved in immune response (GO:0002281) | 3.26450583 |
| 67 | germinal center formation (GO:0002467) | 3.25450564 |
| 68 | cellular extravasation (GO:0045123) | 3.24949176 |
| 69 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.22998885 |
| 70 | immunoglobulin mediated immune response (GO:0016064) | 3.19419969 |
| 71 | response to laminar fluid shear stress (GO:0034616) | 3.19112087 |
| 72 | alpha-beta T cell differentiation (GO:0046632) | 3.17893325 |
| 73 | negative regulation of interleukin-1 production (GO:0032692) | 3.16515764 |
| 74 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.12993178 |
| 75 | leukocyte aggregation (GO:0070486) | 3.12913738 |
| 76 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 3.11793897 |
| 77 | alpha-beta T cell activation (GO:0046631) | 3.11704409 |
| 78 | myeloid dendritic cell differentiation (GO:0043011) | 3.09755749 |
| 79 | regulation of regulatory T cell differentiation (GO:0045589) | 3.09615689 |
| 80 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.07707778 |
| 81 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.06422259 |
| 82 | myeloid dendritic cell activation (GO:0001773) | 3.04603695 |
| 83 | positive regulation of p38MAPK cascade (GO:1900745) | 3.04202727 |
| 84 | T cell differentiation involved in immune response (GO:0002292) | 3.02904092 |
| 85 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.02904092 |
| 86 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.02904092 |
| 87 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.02701990 |
| 88 | negative regulation of interleukin-6 production (GO:0032715) | 3.02078126 |
| 89 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 3.01613077 |
| 90 | regulation of interleukin-2 production (GO:0032663) | 3.01336216 |
| 91 | positive regulation of isotype switching (GO:0045830) | 2.99836766 |
| 92 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.95700632 |
| 93 | leukocyte cell-cell adhesion (GO:0007159) | 2.95227712 |
| 94 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.91771939 |
| 95 | defense response to protozoan (GO:0042832) | 2.91475349 |
| 96 | negative regulation of inclusion body assembly (GO:0090084) | 2.91140547 |
| 97 | neutrophil activation (GO:0042119) | 2.90301789 |
| 98 | positive regulation of heat generation (GO:0031652) | 2.89960359 |
| 99 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.89892865 |
| 100 | positive regulation of tolerance induction (GO:0002645) | 2.89528980 |
| 101 | response to protozoan (GO:0001562) | 2.88271586 |
| 102 | granulocyte activation (GO:0036230) | 2.87064854 |
| 103 | regulation of fever generation (GO:0031620) | 2.86851127 |
| 104 | B cell homeostasis (GO:0001782) | 2.85836266 |
| 105 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.85706261 |
| 106 | detection of external biotic stimulus (GO:0098581) | 2.85383254 |
| 107 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.83345378 |
| 108 | cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) | 2.83116819 |
| 109 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.82407383 |
| 110 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.82018507 |
| 111 | T cell differentiation (GO:0030217) | 2.81882832 |
| 112 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.80266672 |
| 113 | positive regulation of B cell differentiation (GO:0045579) | 2.79287252 |
| 114 | mannose metabolic process (GO:0006013) | 2.78595448 |
| 115 | endoderm formation (GO:0001706) | 2.77098005 |
| 116 | protein K11-linked deubiquitination (GO:0035871) | 2.76906548 |
| 117 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.76845266 |
| 118 | regulation of p38MAPK cascade (GO:1900744) | 2.74894157 |
| 119 | T cell costimulation (GO:0031295) | 2.74886030 |
| 120 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.73638603 |
| 121 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.72448156 |
| 122 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.72103298 |
| 123 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.71894354 |
| 124 | lymphocyte homeostasis (GO:0002260) | 2.70390936 |
| 125 | leukocyte tethering or rolling (GO:0050901) | 2.68668267 |
| 126 | lymphocyte costimulation (GO:0031294) | 2.68150907 |
| 127 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.67668274 |
| 128 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.66475173 |
| 129 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.66475173 |
| 130 | growth hormone receptor signaling pathway (GO:0060396) | 2.66222670 |
| 131 | myeloid cell activation involved in immune response (GO:0002275) | 2.65409725 |
| 132 | JAK-STAT cascade (GO:0007259) | 2.64832636 |
| 133 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.64074594 |
| 134 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.63655136 |
| 135 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.63169187 |
| 136 | regulation of bone resorption (GO:0045124) | 2.62975414 |
| 137 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.62639974 |
| 138 | regulation of tolerance induction (GO:0002643) | 2.62450757 |
| 139 | regulation of B cell differentiation (GO:0045577) | 2.61912331 |
| 140 | detection of biotic stimulus (GO:0009595) | 2.61280033 |
| 141 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.60624320 |
| 142 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.60275583 |
| 143 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.56953486 |
| 144 | B cell receptor signaling pathway (GO:0050853) | 2.55064506 |
| 145 | regulation of alpha-beta T cell activation (GO:0046634) | 2.54321390 |
| 146 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.54218351 |
| 147 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.54036008 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.44129379 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.80101452 |
| 3 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.49888938 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.08960757 |
| 5 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.60796467 |
| 6 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.32623012 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.25929170 |
| 8 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.12211702 |
| 9 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.08390621 |
| 10 | * MYC_22102868_ChIP-Seq_BL_Human | 2.94496509 |
| 11 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.57808029 |
| 12 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.55476345 |
| 13 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.54743720 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.52684276 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.46812480 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.42816007 |
| 17 | * MYB_26560356_Chip-Seq_TH2_Human | 2.40059424 |
| 18 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.38896314 |
| 19 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.36082554 |
| 20 | * MAF_26560356_Chip-Seq_TH1_Human | 2.31815378 |
| 21 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.31073988 |
| 22 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.29319890 |
| 23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.29312473 |
| 24 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.20283964 |
| 25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.15888670 |
| 26 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.10575577 |
| 27 | * MYB_26560356_Chip-Seq_TH1_Human | 2.07950955 |
| 28 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.05862600 |
| 29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.00525660 |
| 30 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.96044934 |
| 31 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.94528117 |
| 32 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.92049023 |
| 33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.90490730 |
| 34 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.89284763 |
| 35 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.89236573 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.85529631 |
| 37 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.82995508 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.81820079 |
| 39 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.78088998 |
| 40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.77202754 |
| 41 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.71692944 |
| 42 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.68847113 |
| 43 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.66441429 |
| 44 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.64879323 |
| 45 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64675288 |
| 46 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.60422724 |
| 47 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55388516 |
| 48 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.53012290 |
| 49 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.50454950 |
| 50 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.50050835 |
| 51 | MAF_26560356_Chip-Seq_TH2_Human | 1.43809036 |
| 52 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.43691123 |
| 53 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.40387642 |
| 54 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.38427998 |
| 55 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.37931228 |
| 56 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.33921117 |
| 57 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.32368848 |
| 58 | SPI1_23127762_ChIP-Seq_K562_Human | 1.26418146 |
| 59 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.24836060 |
| 60 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24707686 |
| 61 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.21661938 |
| 62 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.21508773 |
| 63 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20383528 |
| 64 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17274355 |
| 65 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15365971 |
| 66 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15124977 |
| 67 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.14555665 |
| 68 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13420079 |
| 69 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13263282 |
| 70 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.13170540 |
| 71 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.12749648 |
| 72 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.12648501 |
| 73 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.12407562 |
| 74 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.08652486 |
| 75 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.08457216 |
| 76 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08204893 |
| 77 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.06634374 |
| 78 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.05660413 |
| 79 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.05379576 |
| 80 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04979142 |
| 81 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.04319539 |
| 82 | KDM2B_26808549_Chip-Seq_K562_Human | 1.03819695 |
| 83 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02490712 |
| 84 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01548286 |
| 85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.01012535 |
| 86 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.00514691 |
| 87 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.00354185 |
| 88 | ATF3_27146783_Chip-Seq_COLON_Human | 0.99852006 |
| 89 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99599943 |
| 90 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.99389304 |
| 91 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99120880 |
| 92 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98957473 |
| 93 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98210587 |
| 94 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.98020246 |
| 95 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.97401164 |
| 96 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97222845 |
| 97 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.97185186 |
| 98 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.96633977 |
| 99 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.96515060 |
| 100 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.95588488 |
| 101 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95073362 |
| 102 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.94842839 |
| 103 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.93915817 |
| 104 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92655583 |
| 105 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.92460416 |
| 106 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.92222694 |
| 107 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.92182568 |
| 108 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.90527103 |
| 109 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89956974 |
| 110 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.88323799 |
| 111 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.86732327 |
| 112 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.86732327 |
| 113 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.86408865 |
| 114 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85503948 |
| 115 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85004572 |
| 116 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.84013947 |
| 117 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.83271097 |
| 118 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83134399 |
| 119 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.82651254 |
| 120 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.81280102 |
| 121 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.81234228 |
| 122 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81212102 |
| 123 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81196450 |
| 124 | GATA3_26560356_Chip-Seq_TH2_Human | 0.80128526 |
| 125 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.79906256 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000685_abnormal_immune_system | 3.97582468 |
| 2 | MP0003763_abnormal_thymus_physiology | 3.76344788 |
| 3 | MP0003724_increased_susceptibility_to | 3.54516659 |
| 4 | MP0004510_myositis | 3.16678292 |
| 5 | MP0003303_peritoneal_inflammation | 3.09525549 |
| 6 | MP0005671_abnormal_response_to | 3.03527335 |
| 7 | MP0001790_abnormal_immune_system | 3.01439011 |
| 8 | MP0005387_immune_system_phenotype | 3.01439011 |
| 9 | * MP0005000_abnormal_immune_tolerance | 2.79195342 |
| 10 | MP0003436_decreased_susceptibility_to | 2.71773582 |
| 11 | * MP0001800_abnormal_humoral_immune | 2.69126016 |
| 12 | MP0003300_gastrointestinal_ulcer | 2.61666116 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.55215431 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.51424922 |
| 15 | * MP0002723_abnormal_immune_serum | 2.51276431 |
| 16 | MP0002405_respiratory_system_inflammati | 2.46715390 |
| 17 | MP0006082_CNS_inflammation | 2.39308867 |
| 18 | * MP0002452_abnormal_antigen_presenting | 2.34205631 |
| 19 | * MP0002420_abnormal_adaptive_immunity | 2.25328669 |
| 20 | * MP0004947_skin_inflammation | 2.23193316 |
| 21 | * MP0001819_abnormal_immune_cell | 2.23176631 |
| 22 | MP0002933_joint_inflammation | 2.22020723 |
| 23 | MP0009785_altered_susceptibility_to | 2.21438615 |
| 24 | MP0010155_abnormal_intestine_physiology | 2.18095519 |
| 25 | MP0001851_eye_inflammation | 2.11794921 |
| 26 | MP0009278_abnormal_bone_marrow | 2.10910214 |
| 27 | MP0002166_altered_tumor_susceptibility | 2.08696499 |
| 28 | MP0002419_abnormal_innate_immunity | 2.02667601 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 1.98973738 |
| 30 | MP0005025_abnormal_response_to | 1.94755763 |
| 31 | MP0002398_abnormal_bone_marrow | 1.94631772 |
| 32 | MP0001873_stomach_inflammation | 1.92228820 |
| 33 | * MP0000716_abnormal_immune_system | 1.83165073 |
| 34 | MP0002254_reproductive_system_inflammat | 1.78988882 |
| 35 | MP0001853_heart_inflammation | 1.78461709 |
| 36 | MP0005058_abnormal_lysosome_morphology | 1.76793240 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.76365205 |
| 38 | * MP0001845_abnormal_inflammatory_respons | 1.70898823 |
| 39 | MP0000703_abnormal_thymus_morphology | 1.70088026 |
| 40 | MP0003866_abnormal_defecation | 1.63864817 |
| 41 | MP0002006_tumorigenesis | 1.62866288 |
| 42 | * MP0001533_abnormal_skeleton_physiology | 1.60364897 |
| 43 | MP0000858_altered_metastatic_potential | 1.60115853 |
| 44 | MP0002722_abnormal_immune_system | 1.59956291 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.57365768 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.57054941 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.57054941 |
| 48 | MP0000689_abnormal_spleen_morphology | 1.56545011 |
| 49 | MP0008007_abnormal_cellular_replicative | 1.52057374 |
| 50 | MP0010352_gastrointestinal_tract_polyps | 1.50714516 |
| 51 | MP0005076_abnormal_cell_differentiation | 1.48210322 |
| 52 | MP0008004_abnormal_stomach_pH | 1.46784587 |
| 53 | MP0008961_abnormal_basal_metabolism | 1.46111110 |
| 54 | * MP0002429_abnormal_blood_cell | 1.45577174 |
| 55 | MP0003172_abnormal_lysosome_physiology | 1.44206008 |
| 56 | MP0005464_abnormal_platelet_physiology | 1.44127499 |
| 57 | MP0004808_abnormal_hematopoietic_stem | 1.43557224 |
| 58 | MP0003075_altered_response_to | 1.43148659 |
| 59 | MP0003453_abnormal_keratinocyte_physiol | 1.38710926 |
| 60 | MP0002877_abnormal_melanocyte_morpholog | 1.33651442 |
| 61 | MP0003448_altered_tumor_morphology | 1.31567955 |
| 62 | MP0005451_abnormal_body_composition | 1.30193860 |
| 63 | MP0008260_abnormal_autophagy | 1.21069001 |
| 64 | * MP0002998_abnormal_bone_remodeling | 1.20846908 |
| 65 | MP0000343_altered_response_to | 1.17950685 |
| 66 | MP0003045_fibrosis | 1.16828567 |
| 67 | MP0003828_pulmonary_edema | 1.16138997 |
| 68 | MP0005310_abnormal_salivary_gland | 1.14916901 |
| 69 | MP0003566_abnormal_cell_adhesion | 1.13892075 |
| 70 | MP0002277_abnormal_respiratory_mucosa | 1.13755399 |
| 71 | MP0003091_abnormal_cell_migration | 1.11292031 |
| 72 | MP0005023_abnormal_wound_healing | 1.09884654 |
| 73 | * MP0008469_abnormal_protein_level | 1.09742022 |
| 74 | MP0001243_abnormal_dermal_layer | 1.07581194 |
| 75 | MP0004381_abnormal_hair_follicle | 1.04798709 |
| 76 | MP0000249_abnormal_blood_vessel | 1.04522452 |
| 77 | MP0002928_abnormal_bile_duct | 1.03270449 |
| 78 | MP0005164_abnormal_response_to | 1.02879435 |
| 79 | MP0004883_abnormal_blood_vessel | 0.99883148 |
| 80 | MP0002396_abnormal_hematopoietic_system | 0.98236228 |
| 81 | MP0010368_abnormal_lymphatic_system | 0.93485711 |
| 82 | MP0000604_amyloidosis | 0.91940049 |
| 83 | MP0003279_aneurysm | 0.90170615 |
| 84 | MP0005166_decreased_susceptibility_to | 0.89790087 |
| 85 | MP0001216_abnormal_epidermal_layer | 0.88384456 |
| 86 | MP0000609_abnormal_liver_physiology | 0.87827586 |
| 87 | * MP0005390_skeleton_phenotype | 0.87333793 |
| 88 | MP0001881_abnormal_mammary_gland | 0.83412027 |
| 89 | * MP0003795_abnormal_bone_structure | 0.80443337 |
| 90 | MP0001348_abnormal_lacrimal_gland | 0.80068694 |
| 91 | MP0001663_abnormal_digestive_system | 0.79651365 |
| 92 | MP0009840_abnormal_foam_cell | 0.78500248 |
| 93 | MP0003690_abnormal_glial_cell | 0.77476110 |
| 94 | MP0005165_increased_susceptibility_to | 0.75723982 |
| 95 | MP0003656_abnormal_erythrocyte_physiolo | 0.75492459 |
| 96 | MP0009763_increased_sensitivity_to | 0.74458633 |
| 97 | MP0003191_abnormal_cellular_cholesterol | 0.74156330 |
| 98 | MP0002332_abnormal_exercise_endurance | 0.73455929 |
| 99 | MP0003638_abnormal_response/metabolism_ | 0.72920503 |
| 100 | MP0009764_decreased_sensitivity_to | 0.72487923 |
| 101 | MP0001501_abnormal_sleep_pattern | 0.68693948 |
| 102 | * MP0001191_abnormal_skin_condition | 0.67408073 |
| 103 | * MP0002136_abnormal_kidney_physiology | 0.66635265 |
| 104 | MP0010234_abnormal_vibrissa_follicle | 0.65821129 |
| 105 | MP0001879_abnormal_lymphatic_vessel | 0.65098739 |
| 106 | MP0003183_abnormal_peptide_metabolism | 0.64795467 |
| 107 | MP0003705_abnormal_hypodermis_morpholog | 0.63891275 |
| 108 | MP0005666_abnormal_adipose_tissue | 0.60968979 |
| 109 | MP0000490_abnormal_crypts_of | 0.60933879 |
| 110 | MP0002796_impaired_skin_barrier | 0.60460402 |
| 111 | MP0001958_emphysema | 0.59489744 |
| 112 | MP0004130_abnormal_muscle_cell | 0.59318054 |
| 113 | MP0001502_abnormal_circadian_rhythm | 0.58712114 |
| 114 | MP0009765_abnormal_xenobiotic_induced | 0.57751081 |
| 115 | MP0002009_preneoplasia | 0.57369730 |
| 116 | MP0002132_abnormal_respiratory_system | 0.57155000 |
| 117 | MP0008873_increased_physiological_sensi | 0.57131240 |
| 118 | MP0008874_decreased_physiological_sensi | 0.53958852 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 6.95627993 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.95796500 |
| 3 | Increased density of long bones (HP:0006392) | 5.18211591 |
| 4 | Myositis (HP:0100614) | 5.12396930 |
| 5 | Orchitis (HP:0100796) | 4.87320095 |
| 6 | Optic neuritis (HP:0100653) | 4.78782574 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 4.78782574 |
| 8 | Persistence of primary teeth (HP:0006335) | 4.48180786 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.20758181 |
| 10 | Eczematoid dermatitis (HP:0000976) | 4.07195383 |
| 11 | Nasal polyposis (HP:0100582) | 3.96515978 |
| 12 | IgM deficiency (HP:0002850) | 3.93034708 |
| 13 | Abnormality of the nasal mucosa (HP:0000433) | 3.83443978 |
| 14 | Arterial thrombosis (HP:0004420) | 3.66775858 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.48787296 |
| 16 | Keratoconjunctivitis sicca (HP:0001097) | 3.46440040 |
| 17 | Pulmonary infiltrates (HP:0002113) | 3.38991327 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.37994277 |
| 19 | Chronic otitis media (HP:0000389) | 3.36709873 |
| 20 | Recurrent bronchitis (HP:0002837) | 3.30629106 |
| 21 | Keratoconjunctivitis (HP:0001096) | 3.27108995 |
| 22 | Cerebral aneurysm (HP:0004944) | 3.27017245 |
| 23 | T lymphocytopenia (HP:0005403) | 3.26507532 |
| 24 | Hemoptysis (HP:0002105) | 3.17600516 |
| 25 | Abnormality of T cell number (HP:0011839) | 3.17105692 |
| 26 | Mediastinal lymphadenopathy (HP:0100721) | 3.14064044 |
| 27 | Vasculitis (HP:0002633) | 3.10222206 |
| 28 | Gastrointestinal infarctions (HP:0005244) | 3.05039691 |
| 29 | Dysostosis multiplex (HP:0000943) | 2.98566451 |
| 30 | Interstitial pulmonary disease (HP:0006530) | 2.95734473 |
| 31 | Aortic aneurysm (HP:0004942) | 2.95394976 |
| 32 | Chronic diarrhea (HP:0002028) | 2.95257554 |
| 33 | IgG deficiency (HP:0004315) | 2.90982463 |
| 34 | Abnormality of glycolipid metabolism (HP:0010969) | 2.90924283 |
| 35 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.90924283 |
| 36 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.90924283 |
| 37 | Abnormality of T cells (HP:0002843) | 2.89954637 |
| 38 | Obstructive lung disease (HP:0006536) | 2.87906999 |
| 39 | Chronic obstructive pulmonary disease (HP:0006510) | 2.87906999 |
| 40 | Spontaneous hematomas (HP:0007420) | 2.80383694 |
| 41 | Autoimmune hemolytic anemia (HP:0001890) | 2.78384700 |
| 42 | Hematochezia (HP:0002573) | 2.77516242 |
| 43 | Increased IgE level (HP:0003212) | 2.77209437 |
| 44 | Leukocytosis (HP:0001974) | 2.73327441 |
| 45 | Recurrent abscess formation (HP:0002722) | 2.72533661 |
| 46 | Aortic dissection (HP:0002647) | 2.72167458 |
| 47 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.65685899 |
| 48 | Recurrent cutaneous fungal infections (HP:0011370) | 2.65685899 |
| 49 | Abnormality of eosinophils (HP:0001879) | 2.65625286 |
| 50 | Severe combined immunodeficiency (HP:0004430) | 2.64597883 |
| 51 | Pulmonary embolism (HP:0002204) | 2.60169854 |
| 52 | Arterial tortuosity (HP:0005116) | 2.59311474 |
| 53 | Abnormality of T cell physiology (HP:0011840) | 2.56257606 |
| 54 | Recurrent bacterial skin infections (HP:0005406) | 2.55631558 |
| 55 | Autoimmune thrombocytopenia (HP:0001973) | 2.55569333 |
| 56 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.53550174 |
| 57 | Thyroiditis (HP:0100646) | 2.52838418 |
| 58 | Increased IgM level (HP:0003496) | 2.52245029 |
| 59 | Inflammation of the large intestine (HP:0002037) | 2.51656278 |
| 60 | Recurrent viral infections (HP:0004429) | 2.49611456 |
| 61 | Vascular tortuosity (HP:0004948) | 2.46190625 |
| 62 | Prolonged bleeding time (HP:0003010) | 2.45228588 |
| 63 | Amyloidosis (HP:0011034) | 2.44372461 |
| 64 | IgA deficiency (HP:0002720) | 2.42760765 |
| 65 | Verrucae (HP:0200043) | 2.42502284 |
| 66 | Papilloma (HP:0012740) | 2.42502284 |
| 67 | Joint swelling (HP:0001386) | 2.40574706 |
| 68 | Urticaria (HP:0001025) | 2.40391270 |
| 69 | Emphysema (HP:0002097) | 2.40273662 |
| 70 | Loss of speech (HP:0002371) | 2.38929207 |
| 71 | Colitis (HP:0002583) | 2.38806689 |
| 72 | Gastrointestinal inflammation (HP:0004386) | 2.38052698 |
| 73 | Pustule (HP:0200039) | 2.36547812 |
| 74 | Granulocytopenia (HP:0001913) | 2.34321248 |
| 75 | Increased cerebral lipofuscin (HP:0011813) | 2.30982309 |
| 76 | Combined immunodeficiency (HP:0005387) | 2.27168196 |
| 77 | Myocardial infarction (HP:0001658) | 2.26978612 |
| 78 | Dilatation of the ascending aorta (HP:0005111) | 2.25590210 |
| 79 | Recurrent skin infections (HP:0001581) | 2.24444897 |
| 80 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.24168556 |
| 81 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.24168556 |
| 82 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.24168556 |
| 83 | Gastrointestinal stroma tumor (HP:0100723) | 2.23890045 |
| 84 | Gingivitis (HP:0000230) | 2.21922716 |
| 85 | Chest pain (HP:0100749) | 2.21585788 |
| 86 | Meningitis (HP:0001287) | 2.20903948 |
| 87 | Striae distensae (HP:0001065) | 2.20757277 |
| 88 | Increased serum ferritin (HP:0003281) | 2.20637162 |
| 89 | Episodic fever (HP:0001954) | 2.18500839 |
| 90 | Mitral valve prolapse (HP:0001634) | 2.18233829 |
| 91 | Mucopolysacchariduria (HP:0008155) | 2.17634607 |
| 92 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.17634607 |
| 93 | Depressed nasal tip (HP:0000437) | 2.16902607 |
| 94 | Agammaglobulinemia (HP:0004432) | 2.14541350 |
| 95 | Hypergammaglobulinemia (HP:0010702) | 2.12851991 |
| 96 | Systemic lupus erythematosus (HP:0002725) | 2.12392893 |
| 97 | Restrictive lung disease (HP:0002091) | 2.11060362 |
| 98 | Eosinophilia (HP:0001880) | 2.10698007 |
| 99 | Premature loss of primary teeth (HP:0006323) | 2.08514531 |
| 100 | Slow saccadic eye movements (HP:0000514) | 2.05711119 |
| 101 | Abnormality of the pericardium (HP:0001697) | 2.05518726 |
| 102 | Malnutrition (HP:0004395) | 2.05479656 |
| 103 | Epistaxis (HP:0000421) | 2.05146139 |
| 104 | Gangrene (HP:0100758) | 2.05109613 |
| 105 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.04693917 |
| 106 | Fatigue (HP:0012378) | 2.04263702 |
| 107 | Abnormality of the pleura (HP:0002103) | 2.01729989 |
| 108 | Anorexia (HP:0002039) | 2.01546994 |
| 109 | Vacuolated lymphocytes (HP:0001922) | 2.00658448 |
| 110 | Osteomyelitis (HP:0002754) | 1.99967033 |
| 111 | Glomerulopathy (HP:0100820) | 1.97945079 |
| 112 | Lymphopenia (HP:0001888) | 1.97352458 |
| 113 | Polycythemia (HP:0001901) | 1.97131709 |
| 114 | Peritonitis (HP:0002586) | 1.96695881 |
| 115 | Abnormality of the prostate (HP:0008775) | 1.96492262 |
| 116 | Panhypogammaglobulinemia (HP:0003139) | 1.96007957 |
| 117 | Cellulitis (HP:0100658) | 1.95606479 |
| 118 | Thrombocytosis (HP:0001894) | 1.95413036 |
| 119 | Obstructive sleep apnea (HP:0002870) | 1.95045896 |
| 120 | Thrombophlebitis (HP:0004418) | 1.94289410 |
| 121 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.90751433 |
| 122 | Disproportionate tall stature (HP:0001519) | 1.90091075 |
| 123 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.88986106 |
| 124 | Arthralgia (HP:0002829) | 1.86969197 |
| 125 | Recurrent sinusitis (HP:0011108) | 1.85051040 |
| 126 | Sepsis (HP:0100806) | 1.84948282 |
| 127 | Abnormality of the fingertips (HP:0001211) | 1.84878487 |
| 128 | Hepatitis (HP:0012115) | 1.84136124 |
| 129 | Abnormal platelet function (HP:0011869) | 1.83917908 |
| 130 | Impaired platelet aggregation (HP:0003540) | 1.83917908 |
| 131 | B lymphocytopenia (HP:0010976) | 1.82654315 |
| 132 | Abnormality of B cell number (HP:0010975) | 1.82654315 |
| 133 | Spondylolisthesis (HP:0003302) | 1.82131526 |
| 134 | Encephalitis (HP:0002383) | 1.81869127 |
| 135 | Acrocyanosis (HP:0001063) | 1.80510429 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.77602415 |
| 2 | MAPK15 | 3.56771831 |
| 3 | TXK | 3.56593665 |
| 4 | MAP3K14 | 3.52849646 |
| 5 | PRPF4B | 3.31941293 |
| 6 | ITK | 3.29077783 |
| 7 | TGFBR2 | 2.81324334 |
| 8 | TSSK6 | 2.68656375 |
| 9 | TBK1 | 2.53467207 |
| 10 | IRAK3 | 2.52773303 |
| 11 | JAK3 | 2.47119065 |
| 12 | TYK2 | 2.45498863 |
| 13 | EPHB1 | 2.31552322 |
| 14 | JAK1 | 2.28664863 |
| 15 | TAOK3 | 2.22961260 |
| 16 | IKBKE | 2.20173550 |
| 17 | STK10 | 2.18517797 |
| 18 | IKBKB | 2.17040108 |
| 19 | EPHA3 | 2.11227205 |
| 20 | FGFR4 | 2.00059017 |
| 21 | TEC | 1.92378047 |
| 22 | GRK6 | 1.76297588 |
| 23 | MAP3K13 | 1.73784935 |
| 24 | CHUK | 1.71427805 |
| 25 | ZAP70 | 1.67629803 |
| 26 | ERN1 | 1.66581373 |
| 27 | NLK | 1.63365281 |
| 28 | BTK | 1.50622061 |
| 29 | MAP2K2 | 1.48746376 |
| 30 | MAP3K10 | 1.44915117 |
| 31 | TAOK2 | 1.43453639 |
| 32 | HCK | 1.39061186 |
| 33 | TNK2 | 1.28407031 |
| 34 | JAK2 | 1.28126801 |
| 35 | PTK6 | 1.27490101 |
| 36 | CSK | 1.26975455 |
| 37 | LCK | 1.22197090 |
| 38 | TRIB3 | 1.16021829 |
| 39 | MAP2K3 | 1.15511918 |
| 40 | MST4 | 1.13796436 |
| 41 | FGFR3 | 1.13591468 |
| 42 | RPS6KA4 | 1.12417197 |
| 43 | PIM1 | 1.06598993 |
| 44 | TESK2 | 1.03680760 |
| 45 | MARK3 | 0.97666876 |
| 46 | CDC42BPA | 0.96373781 |
| 47 | MARK2 | 0.93683722 |
| 48 | MAP3K3 | 0.92864949 |
| 49 | BMPR2 | 0.92831617 |
| 50 | KDR | 0.91241159 |
| 51 | PKN2 | 0.91219012 |
| 52 | EEF2K | 0.90021215 |
| 53 | FES | 0.88187179 |
| 54 | RIPK1 | 0.87271181 |
| 55 | IRAK2 | 0.86310129 |
| 56 | CAMKK1 | 0.82428730 |
| 57 | IRAK4 | 0.82037157 |
| 58 | MAPK7 | 0.81887062 |
| 59 | IRAK1 | 0.81587427 |
| 60 | GSK3A | 0.80331732 |
| 61 | SYK | 0.80246427 |
| 62 | RPS6KL1 | 0.79618656 |
| 63 | RPS6KC1 | 0.79618656 |
| 64 | LRRK2 | 0.75662592 |
| 65 | PRKD2 | 0.74874358 |
| 66 | FGR | 0.74131201 |
| 67 | GRK7 | 0.72756402 |
| 68 | BLK | 0.71785111 |
| 69 | KIT | 0.71411035 |
| 70 | PRKCH | 0.70881723 |
| 71 | HIPK2 | 0.70239037 |
| 72 | SIK3 | 0.68374283 |
| 73 | CAMKK2 | 0.66195363 |
| 74 | MOS | 0.65360776 |
| 75 | CSF1R | 0.60998121 |
| 76 | TTN | 0.60508952 |
| 77 | PDGFRB | 0.58529774 |
| 78 | MATK | 0.58518313 |
| 79 | PASK | 0.58217526 |
| 80 | SMG1 | 0.58075839 |
| 81 | RPS6KA5 | 0.57713061 |
| 82 | RPS6KA2 | 0.56849095 |
| 83 | MAPKAPK5 | 0.54136652 |
| 84 | MAP3K1 | 0.53473165 |
| 85 | RPS6KA1 | 0.53451255 |
| 86 | PRKCQ | 0.53004396 |
| 87 | PDPK1 | 0.52885756 |
| 88 | MAPK4 | 0.52087207 |
| 89 | MAPK11 | 0.52037995 |
| 90 | RIPK4 | 0.50927095 |
| 91 | PKN1 | 0.49053484 |
| 92 | TAOK1 | 0.48996455 |
| 93 | PIM2 | 0.48442706 |
| 94 | MAP3K7 | 0.48184582 |
| 95 | CLK1 | 0.48184006 |
| 96 | SIK1 | 0.48049166 |
| 97 | MAP3K6 | 0.47364938 |
| 98 | SIK2 | 0.43552770 |
| 99 | MELK | 0.43466930 |
| 100 | TYRO3 | 0.41925313 |
| 101 | MAPKAPK2 | 0.41855184 |
| 102 | RPS6KA6 | 0.41726289 |
| 103 | RET | 0.41019856 |
| 104 | LYN | 0.40903409 |
| 105 | ICK | 0.40355582 |
| 106 | PTK2 | 0.38767560 |
| 107 | FYN | 0.38380768 |
| 108 | INSR | 0.38137237 |
| 109 | CDK4 | 0.37460257 |
| 110 | MAPK12 | 0.37325299 |
| 111 | TRPM7 | 0.37215375 |
| 112 | IGF1R | 0.36987286 |
| 113 | DYRK1B | 0.36745544 |
| 114 | PTK2B | 0.35937531 |
| 115 | PAK2 | 0.35458223 |
| 116 | MAP3K11 | 0.34805571 |
| 117 | MAP3K2 | 0.34590877 |
| 118 | VRK1 | 0.33904354 |
| 119 | TIE1 | 0.32835052 |
| 120 | DMPK | 0.32459848 |
| 121 | CDK12 | 0.32017990 |
| 122 | MAP2K6 | 0.32008607 |
| 123 | TGFBR1 | 0.31686143 |
| 124 | PAK4 | 0.31383515 |
| 125 | ALK | 0.30790454 |
| 126 | CDK6 | 0.30102753 |
| 127 | PDK1 | 0.29071170 |
| 128 | STK11 | 0.28632548 |
| 129 | * MAPK3 | 0.26889116 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.40210643 |
| 2 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 3.02010813 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.93985396 |
| 4 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.80717113 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.72619644 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.64763295 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.36871551 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.26064139 |
| 9 | * TNF signaling pathway_Homo sapiens_hsa04668 | 2.21515294 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.21408149 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.17623765 |
| 12 | Toxoplasmosis_Homo sapiens_hsa05145 | 2.05946392 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.89588190 |
| 14 | Legionellosis_Homo sapiens_hsa05134 | 1.75433026 |
| 15 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.70677111 |
| 16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.65884624 |
| 17 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.57433787 |
| 18 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.54945342 |
| 19 | Allograft rejection_Homo sapiens_hsa05330 | 1.54115656 |
| 20 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.50144382 |
| 21 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.47552147 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.45606454 |
| 23 | Hepatitis B_Homo sapiens_hsa05161 | 1.44214289 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.42326294 |
| 25 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.40023385 |
| 26 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.37999314 |
| 27 | Apoptosis_Homo sapiens_hsa04210 | 1.37335501 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.34745291 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.32889178 |
| 30 | Malaria_Homo sapiens_hsa05144 | 1.28501713 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.25596264 |
| 32 | Pertussis_Homo sapiens_hsa05133 | 1.25278841 |
| 33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.25261142 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.23743218 |
| 35 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.21089483 |
| 36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.19440619 |
| 37 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.18139981 |
| 38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.17181207 |
| 39 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.14306533 |
| 40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.11269716 |
| 41 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.06203953 |
| 42 | HTLV-I infection_Homo sapiens_hsa05166 | 1.05147615 |
| 43 | MAPK signaling pathway_Homo sapiens_hsa04010 | 1.04637041 |
| 44 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.03935925 |
| 45 | Salmonella infection_Homo sapiens_hsa05132 | 1.03478440 |
| 46 | Circadian rhythm_Homo sapiens_hsa04710 | 1.01818004 |
| 47 | Colorectal cancer_Homo sapiens_hsa05210 | 1.01326551 |
| 48 | Prion diseases_Homo sapiens_hsa05020 | 1.00818656 |
| 49 | Tuberculosis_Homo sapiens_hsa05152 | 1.00013108 |
| 50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.99266586 |
| 51 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.98047401 |
| 52 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.97935960 |
| 53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.97317967 |
| 54 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.97195001 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 0.96776797 |
| 56 | Hepatitis C_Homo sapiens_hsa05160 | 0.88573004 |
| 57 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.88286795 |
| 58 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.87855406 |
| 59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86133490 |
| 60 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.81205907 |
| 61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.80394205 |
| 62 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.78035750 |
| 63 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.77741931 |
| 64 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76968543 |
| 65 | Endocytosis_Homo sapiens_hsa04144 | 0.76704191 |
| 66 | Phagosome_Homo sapiens_hsa04145 | 0.75906447 |
| 67 | Asthma_Homo sapiens_hsa05310 | 0.74476303 |
| 68 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.72386937 |
| 69 | Insulin resistance_Homo sapiens_hsa04931 | 0.72228613 |
| 70 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.70507440 |
| 71 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.68962345 |
| 72 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.66442537 |
| 73 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.65356794 |
| 74 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.64280717 |
| 75 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64087866 |
| 76 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.62621913 |
| 77 | Amoebiasis_Homo sapiens_hsa05146 | 0.62042728 |
| 78 | Focal adhesion_Homo sapiens_hsa04510 | 0.60729661 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57131480 |
| 80 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.56690987 |
| 81 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56520280 |
| 82 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.54098438 |
| 83 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.52180860 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51326914 |
| 85 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49908623 |
| 86 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49762171 |
| 87 | Pathways in cancer_Homo sapiens_hsa05200 | 0.48619597 |
| 88 | Prostate cancer_Homo sapiens_hsa05215 | 0.48161370 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48087959 |
| 90 | Bladder cancer_Homo sapiens_hsa05219 | 0.47940731 |
| 91 | Other glycan degradation_Homo sapiens_hsa00511 | 0.47841462 |
| 92 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.47242312 |
| 93 | Lysosome_Homo sapiens_hsa04142 | 0.46966669 |
| 94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46449613 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.46127045 |
| 96 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.45967880 |
| 97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45426291 |
| 98 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45216556 |
| 99 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.43662280 |
| 100 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.42270495 |
| 101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42009240 |
| 102 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.39722488 |
| 103 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38922653 |
| 104 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38174902 |
| 105 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.37767060 |
| 106 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.37451144 |
| 107 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37151861 |
| 108 | Adherens junction_Homo sapiens_hsa04520 | 0.37054405 |
| 109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.36717729 |
| 110 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.35560226 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34392378 |
| 112 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.33804464 |
| 113 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.31068587 |

